Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis
用于增强蛋白质分析的相变牺牲层微流体
基本信息
- 批准号:7755902
- 负责人:
- 金额:$ 29.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2012-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesBenchmarkingBiologicalBiological AssayBiological MarkersBiological SciencesBloodBlood specimenBuffersCapillary ElectrophoresisComplexComplex MixturesDetectionDevelopmentDevicesDisciplineDiseaseDrug FormulationsFluorescenceGenetic Crossing OverHumanInjection of therapeutic agentIonic StrengthsIonsLabelLiquid substanceMalignant NeoplasmsMedical ResearchMembraneMethodologyMethodsMicrochip Analytical ProceduresMicrochip ElectrophoresisMicrofabricationMicrofluidic MicrochipsMicrofluidicsModificationPerformancePolyethylene TerephthalatesPolymersPolystyrenesProceduresProcessProtein AnalysisProteinsSamplingSolutionsSolventsSpeedSurfaceSystemSystems AnalysisTechniquesTestingUrinealpha-Fetoproteinsbaseclinical Diagnosisclinically relevantcostfetalimprovedmicrochipmicrosystemsminiaturizephase changepolycarbonatepolymerizationprotein complextool
项目摘要
The continued development of new tools and techniques that improve sensitivity, selectivity, speed and
throughput in biological analysis, while reducing the cost per assay, will be critical in clinical diagnosis,
medical research, and other disciplines in the life sciences. Micromachining methods have the potential to
enable the construction of low-cost, yet sophisticated microfluidic systems for the analysis of complex protein
mixtures. Herein, we propose to develop a phase-changing sacrificial layer (PCSL) microfabrication
approach and polymer surface modification methods to create inexpensive microfluidic devices that can
improve the detection and quantification of alpha-fetoprotein (AFP), a cancer and fetal wellness marker, in
blood and urine. The objectives of this proposal are four-fold. First, we will generalize the PCSL solvent
bonding fabrication technique and atom-transfer radical polymerization surface modification methods to a
range of polymer microfluidic systems for protein analysis. Second, we plan to evaluate the PCSL solvent
bonding approach for making complex, multilayer microfluidic arrays that facilitate the integration of sample
processing steps. Third, we will develop these fabrication techniques to enable the incorporation of
immunoaffinity purification systems and protein sample preconcentrators for use in enhancing detection in
microchip capillary electrophoresis. Fourth, we will utilize the tools from the first three objectives to make
microdevices that extract and preconcentrate lower-abundance proteins such as AFP from biological
mixtures; we will then evaluate these microsystems for the determination of AFP levels in blood and urine.
Importantly, while the studies in this proposal are directed toward the development of miniaturized assays for
AFP, these same fabrication and analysis procedures can be generalized in a straightforward manner to
allow the rapid quantification of other lower-abundance cancer and disease biomarkers. Thus, PCSL
techniques and polymer surface derivatization methods should provide a broadly applicable microchip
platform for the electrophoretic analysis and quantification of proteins or other biomolecules in humans.
新工具和技术的不断发展,提高了灵敏度、选择性、速度和效率
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Thomas Woolley其他文献
Adam Thomas Woolley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Thomas Woolley', 18)}}的其他基金
3D-Printed Integrated Microfluidic Devices for Preterm Birth Biomarker Analysis
用于早产生物标志物分析的 3D 打印集成微流体装置
- 批准号:
10250315 - 财政年份:2018
- 资助金额:
$ 29.11万 - 项目类别:
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis
用于增强蛋白质分析的相变牺牲层微流体
- 批准号:
7350880 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis
用于增强蛋白质分析的相变牺牲层微流体
- 批准号:
7194205 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis
用于增强蛋白质分析的相变牺牲层微流体
- 批准号:
7564711 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis
用于增强蛋白质分析的相变牺牲层微流体
- 批准号:
8212420 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Integrated microfluidic devices for preterm birth biomarker measurement
用于早产生物标志物测量的集成微流体装置
- 批准号:
8442695 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Integrated microfluidic devices for preterm birth biomarker measurement
用于早产生物标志物测量的集成微流体装置
- 批准号:
8701291 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis
用于增强蛋白质分析的相变牺牲层微流体
- 批准号:
7079019 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein Analysis
用于增强蛋白质分析的相变牺牲层微流体
- 批准号:
8021802 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
Integrated microfluidic devices for preterm birth biomarker measurement
用于早产生物标志物测量的集成微流体装置
- 批准号:
9087225 - 财政年份:2006
- 资助金额:
$ 29.11万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别: